| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |